Malignant Adenofibroma, also known as adenocarcinofibroma, is related to ovarian clear cell malignant adenofibroma and ovarian mucinous malignant adenofibroma. An important gene associated with Malignant Adenofibroma is LYZ (Lysozyme), and among its related pathways/superpathways is Supression of HMGB1 mediated inflammation by THBD. The drugs Paclitaxel and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial and ovary, and related phenotypes are normal and liver/biliary system